These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8414680)

  • 1. [In vitro pharmacological study of fluconazole. Evaluation of an antifungal assay].
    Duval F; Lavarde V
    Pathol Biol (Paris); 1993 May; 41(5):469-73. PubMed ID: 8414680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro evaluation of the sensitivity to fluconazole of different species of yeasts isolated in pathology].
    Regli P; Blancard A; Goudard M; Moulin-Traffort J; Sarzier JM; Quilici M
    Pathol Biol (Paris); 1992 May; 40(5):500-6. PubMed ID: 1495834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CHROMAgar Candida with fluconazole: comparison with microdilution techniques].
    Linares MJ; Charriel G; Solís F; Casal M
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):493-7. PubMed ID: 14572382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
    Linares MJ; Muñoz JF; Solís F; Rodríguez FC; Valero A; Casal M
    Rev Esp Quimioter; 1998 Mar; 11(1):64-9. PubMed ID: 9795292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antifungal susceptibility of yeasts by Etest. Comparison of 3 media].
    Tapia C; León E; Palavecino E
    Rev Med Chil; 2003 Mar; 131(3):299-302. PubMed ID: 12790079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation and utility of the E-test and Neo-Sensitabs methods in studying fluconazole yeast susceptibility].
    Cantón E; Pemán J; Sastre M; Valentín A; Bosch M; Espinel-Ingroff A
    Rev Esp Quimioter; 2006 Sep; 19(3):267-74. PubMed ID: 17099795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of fluconazole on Candida albicans.
    Abecia LC; Arévalo JM; López MJ
    Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of Candida species' susceptibility to fluconazole with the disk diffusion method].
    de Bedout C; Ayabaca J; Vega R; Méndez M; Santiago AR; Pabón ML; Tabares A; Arango M; Restrepo A; Newell V
    Biomedica; 2003 Mar; 23(1):31-7. PubMed ID: 12696397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro fluconazole susceptibility of 1565 clinical isolates of Candida species evaluated by the disk diffusion method performed using NCCLS M44-A guidelines.
    Testore GP; Dori L; Buonomini AR; Schito GC; Soro O; Fortina G; Andreoni S; Carlone N; Tullio V; Andreoni M
    Diagn Microbiol Infect Dis; 2004 Nov; 50(3):187-92. PubMed ID: 15541604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
    Yamane N; Igari J
    Rinsho Byori; 1997 Feb; 45(2):190-9. PubMed ID: 9121005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of a breakpoint test for determination of fluconazole susceptibility of yeasts].
    Fegeler W
    Mycoses; 1997; 40 Suppl 1():47-52. PubMed ID: 9417513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M; Karaman M
    Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole activity against clinical yeast isolates: a multicentre Italian study.
    Morace G; Polonelli L;
    Int J Antimicrob Agents; 2005 Sep; 26(3):247-53. PubMed ID: 16051469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicenter study of fungemia due to yeasts in Argentina].
    Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A;
    Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
    Swinne D; Watelle M; Van der Flaes M; Nolard N
    Mycoses; 2004 Jun; 47(5-6):177-83. PubMed ID: 15189180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal activity of Turkish honey against Candida spp. and Trichosporon spp: an in vitro evaluation.
    Koc AN; Silici S; Ercal BD; Kasap F; Hörmet-Oz HT; Mavus-Buldu H
    Med Mycol; 2009 Nov; 47(7):707-12. PubMed ID: 19888803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):113-7. PubMed ID: 15474320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.